Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Lexicon Pharmaceuticals, Inc. (LXRX) had Debt to Capital Ratio of 0.31 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$5.49M |
|
$-15.53M |
|
$0.20M |
|
$5.29M |
|
$20.27M |
|
$-14.78M |
|
$-0.75M |
|
$-15.53M |
|
$-15.53M |
|
$-15.53M |
|
$-15.53M |
|
$-15.53M |
|
$-15.53M |
|
$-14.78M |
|
$-14.17M |
|
363.05M |
|
363.05M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$101.89M |
|
$1.86M |
|
$83.09M |
|
$184.99M |
|
$20.87M |
|
$49.41M |
|
$56.58M |
|
$77.45M |
|
$107.54M |
|
$62.99M |
|
$107.54M |
|
365.85M |
|
| Cash Flow Statement Financials | |
$-67.85M |
|
$113.02M |
|
$-48.50M |
|
$66.66M |
|
$63.33M |
|
$-3.33M |
|
$12.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.88 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.31 |
0.50 |
|
96.34% |
|
-269.09% |
|
-269.09% |
|
-- |
|
-282.71% |
|
-282.71% |
|
$-67.85M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.72 |
|
2.30 |
|
39.06 |
|
-14.44% |
|
-24.65% |
|
-8.39% |
|
-9.89% |
|
$0.29 |
|
$-0.19 |
|
$-0.19 |
|